Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment 2024-08-27 09:00
Fujitsu tackles 'drug loss' in Japan through ecosystem to accelerate digitalization of clinical trials 2024-08-27 08:07
Experts Agree On the Longevity of EMFACE's Non-Invasive Face-Lifting Effects 2024-08-27 08:00
Telix Announces Reorganisation to Deliver on Strategic Priorities 2024-08-27 07:15
Kaiyi Healthcare: Pioneering Medical Innovation, Deepening Brand Essence, and Shaping a Healthier Future Together 2024-08-27 07:00
TraceLink Becomes First Solution Provider to Secure All 16 GS1 US Conformance Trustmarks for EPCIS File Support 2024-08-26 23:31
Mabwell Announces CDE Approval to Initiate Phase III Clinical Trial of 9MW2821 for Urothelial Carcinoma in Combination with PD-1 Inhibitor 2024-08-26 22:00
About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron 2024-08-26 21:25
World-Renowned Scientist Wah Chiu, Stanford University Professor and Honorary Advisor to Pohang City, visited Korea at the invitation of the Coree Group 2024-08-26 21:00
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration 2024-08-26 21:00
Peijia Medical Announces 2024 Interim Results 2024-08-26 20:30
Actinogen announces further positive results on depression in the XanCIDD phase 2a trial 2024-08-26 20:30
I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference 2024-08-26 19:00
Meihua International Medical Technologies Co., Ltd. to Present at LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar on August 28, 2024 2024-08-26 18:00
Australian Brand Witsbb Upgrades Its Health Focus After Years in the Maternal and Child Nutrition Sector, Offering Better Care for Babies 2024-08-26 15:46
CStone Reports 2024 Interim Results and Recent Corporate Updates 2024-08-23 22:20
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC to Initiate Phase III Clinical Trial for the Treatment of Cervical Cancer 2024-08-23 22:00
UTime Limited to Participate in International Medical Fairs and Medical Conferences 2024-08-23 21:25
CanariaBio Inc Announces Enrollment Completion of randomized Phase 2 study of Oregovomab in combination with chemotherapy as neo-adjuvant treatment of patients with Advanced Ovarian Cancer 2024-08-23 20:00
GenFleet Announces the First Approval of a KRAS G12C Inhibitor in China for Treatment of Advanced Non-small Cell Lung Cancer Patients Harboring KRAS G12C Mutation 2024-08-23 19:30
1 45 46 47 48 49 1596